- Home
- AIMD vs DOMH Comparison
AIMD vs DOMH Comparison
Compare AIMD & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- DOMH
- Stock Information
- Founded
- AIMD 1984
- DOMH 1967
- Country
- AIMD United States
- DOMH United States
- Employees
- AIMD N/A
- DOMH N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- AIMD Health Care
- DOMH Health Care
- Exchange
- AIMD Nasdaq
- DOMH Nasdaq
- Market Cap
- AIMD 16.9M
- DOMH 94.0M
- IPO Year
- AIMD N/A
- DOMH N/A
- Fundamental
- Price
- AIMD $3.45
- DOMH $6.07
- Analyst Decision
- AIMD
- DOMH
- Analyst Count
- AIMD 0
- DOMH 0
- Target Price
- AIMD N/A
- DOMH N/A
- AVG Volume (30 Days)
- AIMD 88.6K
- DOMH 304.5K
- Earning Date
- AIMD 11-05-2025
- DOMH 11-07-2025
- Dividend Yield
- AIMD N/A
- DOMH 8.91%
- EPS Growth
- AIMD N/A
- DOMH N/A
- EPS
- AIMD N/A
- DOMH N/A
- Revenue
- AIMD $110,870.00
- DOMH $52,811,000.00
- Revenue This Year
- AIMD N/A
- DOMH N/A
- Revenue Next Year
- AIMD N/A
- DOMH N/A
- P/E Ratio
- AIMD N/A
- DOMH N/A
- Revenue Growth
- AIMD 70.25
- DOMH 455.38
- 52 Week Low
- AIMD $2.00
- DOMH $0.83
- 52 Week High
- AIMD $5.00
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- AIMD 49.78
- DOMH 49.67
- Support Level
- AIMD $3.28
- DOMH $5.90
- Resistance Level
- AIMD $3.83
- DOMH $7.18
- Average True Range (ATR)
- AIMD 0.27
- DOMH 0.46
- MACD
- AIMD -0.06
- DOMH -0.04
- Stochastic Oscillator
- AIMD 18.68
- DOMH 29.30
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.